��������

National Cancer Institute employees must  to communicate about vaccines and 22 other “controversial, high profile or sensitive” topics, according to internal guidance. The list includes the cancer moonshot, bird flu, COVID-19, obesity, measles and diversity/equity efforts. The list’s scope and scale is unprecedented and highly unusual, employees said. An institute clearance team will review the presentations and publications. Critics worry the directive will delay or halt research publication, as well as cause scientists to censor findings due to fear or deference to administration priorities. (ProPublica , 3/10/25)